CORRECTION OF HYPERTENSIVE NEURORETINOPATHY BY DIMETHYLAMINOETHANOL DERIVATIVE 7-16 IN EXPERIMENT
Aim. Increase of efficiency of pharmacological correction of hypertensive neuroretinopathy using a new dimethylaminoethanol (DMAE) derivative 7-16.Materials and methods. Modeling of hypertensive neuroretinopathy was carried out by introducing a nonselective inhibitor of NO-synthase N-nitro-L-arginin...
Main Authors: | A. A. PERESYPKINA, M. V. POKROVSKII, V. O. GUBAREVA, E. A. LEVKOVA |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Healthcare of the Russian Federation. “Kuban State Medical University”
2018-02-01
|
Series: | Кубанский научный медицинский вестник |
Subjects: | |
Online Access: | https://ksma.elpub.ru/jour/article/view/1014 |
Similar Items
-
THE DEVELOPMENT OF HYPERTENSIVE NEURORETINOPATHY
MODEL ON WISTAR RATS
by: Anna Peresypkina, et al.
Published: (2017-03-01) -
Inhibition Effect of N, N'-Dimethylaminoethanol on the Pitting Corrosion Austenitic Stainless Steel Type 304
by: Roland Tolulope LOTO, et al.
Published: (2015-11-01) -
A comparative evaluation of the efficacy of dimethylaminoethanol derivative 7–16, C7070 and picamilon in correction of experimental hypertensive neuroretinopathy
by: Anna A. Peresypkina
Published: (2018-09-01) -
CORRECTION OF RETINAL ANGIOPATHY OF HYPERTENSIVE TYPE BY DIMETHYLAMINOETHANOL DERIVATIVE 19-16 IN EXPERIMENT
by: Anna Peresypkina
Published: (2017-12-01) -
Acute macular neuroretinopathy associated to dengue disease
by: Amir Translateur, et al.
Published: (2022-06-01)